Bristol-Myers Squibb Company Price Today
Bristol-Myers Squibb Company
BMY
Healthcare
$103.57B
💰
Market Cap
13.2
💸
Price to Earnings
$3.9
🎉
EPS
+77
🌳
ESG
Consensus Recommendations
Hold Consensus
Buy |
6 |
Strong Buy |
4 |
Hold |
20 |
Sell |
1 |
Strong Sell |
0 |
BMY Price Forecast Target
51.1 👉 69.1 +35%
BMY EPS Forecast
3.9 👉 6.5 +69%
Financials
Profit Margin
18 %
Revenue Growth
0.6 %
Dividend
$ 2.4
Held Percent
0.1% - Insiders
79.0% - Institutions
20.9% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $10.1B
-
💰 Blackrock Inc. $8.6B
-
💰 JP Morgan Chase & Company $4.6B
-
💰 State Street Corporation $4.6B
-
💰 Capital International Investors $3.1B
Stock Ideas
Stephen Mandel Portfolio
Stephen Mandel is the founder and portfolio manager of Lone Pine Capital, one of the largest and most successful hedge funds. Employing rigorous fundamental analysis, Mandel searches globally for qualitatively excellent growth companies trading at r…
George Soros Portfolio
George Soros is a legendary hedge fund manager who made history when he earned 1 billion in 1992 and became known as 'the Man Who Broke the Bank of England'. "With an estimated net worth of 14.2 billion, Soros is ranked 35th on the list of the world…
David Tepper Portfolio
David Tepper is a renowned billionaire investor, widely known for his incredible success during the 2009 financial crisis where he made a staggering $4 billion. His financial prowess has earned him the distinction of being the 258th richest individ…
Steven Cohen Portfolio
Steven Cohen, the legendary trader and billionaire founder of Stamford-based SAC Capital, has established himself as a force to be reckoned with in the hedge fund industry. With a staggering net worth of $8 billion and an impressive $14 billion in …📮FAQ
Some Frequently Asked Questions.
The Bristol-Myers Squibb Company industry is Drug Manufacturers - General
The Bristol-Myers Squibb Company sector is Healthcare
The Bristol-Myers Squibb Company forecasted predicted Price to Earnings PE ratio is 7.8
The Bristol-Myers Squibb Company Price to Earnings PE ratio is 13.2
The Market Capitalization of Bristol-Myers Squibb Company is $103.57B
There are total of 2018068136 float shares with 79.0% held by Institutions and 0.1% held by insiders
The MBristol-Myers Squibb Company forecasted Earnings per Share EPS is $6.5
The Bristol-Myers Squibb Company Earnings per Share EPS is 3.9
The Bristol-Myers Squibb Company company has $0 gross profits with 18 profit margins
The Bristol-Myers Squibb Company Earnings Growth is -0.089% with -0.129% quarterly earnings growth
The Bristol-Myers Squibb Company Revenue is $45006000128 with 0.006 revenue growth
The price target for Bristol-Myers Squibb Company stock is $69.1 for the high target and $37.8 for the low target
The consensus analyst recommendations for Bristol-Myers Squibb Company is Hold, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Bristol-Myers Squibb Company is Hold, with the following breakdown:
- Buy: 6
- Strong Buy: 4
- Hold: 20
- Sell: 1
- Strong Sell: 0
The Beta of Bristol-Myers Squibb Company is 0.4
The dividend of Bristol-Myers Squibb Company is $2.4
The dividend yield of Bristol-Myers Squibb Company is 0.047%
The biggest institutional and mutual fund holders of Bristol-Myers Squibb Company stock are
- Vanguard Group Inc
- Blackrock Inc.
- JP Morgan Chase & Company
- State Street Corporation
The Bristol-Myers Squibb Company ESG Score is 77, with the following breakdown:
- E: 1.31
- S: 14.37
- G: 7.07